BIIB vs EEX · P/E 21, rev $9.89B vs rev $398.8M
Biogen Inc (BIIB) versus Emerald Expositions Events Inc (EEX) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Emerald Expositions Events Inc (EEX) is a advertising agencies company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported EEX revenue for 2024-12-31 was $398.8M. Net income was $2.2M. Revenue was up 4.2% from 2023-12-31 to 2024-12-31. EEX currently screens at market cap $995.5M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. EEX currently screens at market cap $995.5M.
Not investment advice. Open the BIIB and EEX stock pages for the full models.
Not investment advice.